Marijuana firm MedMen’s fiscal Q2 sales grow, losses shrink from previous quarter
Los Angeles-based MedMen reported revenue of $29.9 million and a net loss of $64.6 million for its fiscal…
News February 27
Latest In: Stocks
GW Pharma denies supply issues with marijuana-based drug Epidiolex after stock falls
GW Pharmaceuticals, the British maker of epileptic seizure-control medication Epidiolex, said it was not aware of any supply…
News February 21
Canadian marijuana grower Village Farms approved for Nasdaq listing
Village Farms International, a Canadian greenhouse grower with a 50% stake in British Columbia-based cannabis firm Pure Sunfarms…
News February 15
After string of successes, multistate cannabis firm MedMen forced to confront adversity
MedMen Enterprises has been hit with three lawsuits that, combined, seek hundreds of millions of dollars in damages.
News February 14
San Francisco cannabis retailer acquired by Canada’s TerrAscend for $118M
Canadian marijuana firm TerrAscend announced it will acquire California-based The Apothecarium in a deal worth more than $118…
News February 11
Auxly, FSD Pharma end cannabis cultivation venture over contractual disputes
Auxly Cannabis Group, a vertically integrated marijuana company in Vancouver, British Columbia, said Thursday it is ending a…
News February 7
Former CFO sues cannabis firm MedMen, alleging breach of contract, other misdeeds
The former chief financial officer of MedMen Enterprises filed suit against the California-based company this week, alleging top executives…
News January 31
Weekly Deal Watch: Sizes of cannabis capital raises climb, though frequency lags
Fundraising among North American cannabis firms has yet to outpace levels logged this time last year, but the…
News January 30
Medical marijuana firm Khiron expands in South America with CA$13.7M acquisition
Khiron Life Sciences, an integrated medical cannabis company with core operations in Colombia, has agreed to buy Uruguay’s…
News January 29
Chart: US-affiliated medical cannabis firms led fundraising on Canadian Securities Exchange in 2018
U.S.-affiliated medical cannabis companies dominated Canadian Securities Exchange (CSE) fundraising in 2018, raising nearly $2 billion through 50…
News January 28
Latest Sponsored
